Daniel Raynor's Net Worth

$40.7 Million

Estimate Recalculated Apr 22, 2024 05:28PM EST

Who is Daniel Raynor?

Daniel Raynor has an estimated net worth of $40.7 Million. This is based on reported shares across multiple companies, which include EQM Technologies & Energy, Inc., ANI PHARMACEUTICALS INC, RESEARCH PHARMACEUTICAL SERVICES, INC., COMFORCE CORP, NUCO2 INC /FL, and TCI SOLUTIONS INC.

SEC CIK

Daniel Raynor's CIK is 0001068854

Past Insider Trading and Trends

2004 was Daniel Raynor's most active year for acquiring shares with 4 total transactions. Daniel Raynor's most active month to acquire stocks was the month of May. 2006 was Daniel Raynor's most active year for disposing of shares, totalling 12 transactions. Daniel Raynor's most active month to dispose stocks was the month of April. 2008 saw Daniel Raynor paying a total of $95,400.00 for 21,000 shares, this is the most they've acquired in one year. In 2015 Daniel Raynor cashed out on 200,000 shares for a total of $12,600,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EQM Technologies & Energy, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 12
Form 3
—
0
—
—
0
No matching records found

ANI PHARMACEUTICALS INC (ANIP) Snapshot price: $56.87

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.44%
-7.21K
$60.85
-$439,047.06
289K
Mar 15 - Mar 19
Form 4
-8.63%
-27.96K
$62.24
-$1,740,552.05
296.22K
Mar 12 - Mar 14
Form 4
+9.89%
1K
—
—
11.11K
Mar 31
Form 4
+10.98%
1K
—
—
10.11K
Apr 7
Form 4
+9.63%
800
—
—
9.11K
Apr 16
Form 4
-38.15%
-200.00K
$63.00
-$12,600,000.00
324.18K
Mar 12
Form 4
—
0
—
—
0
Apr 1
Form 4
-2.30%
-12.35K
$33.85
-$417,945.95
524.18K
Mar 14
Form 4/A
-3.79%
-21.11K
$33.89
-$715,556.35
536.53K
Mar 12
Form 4
-0.63%
-21.11K
$33.89
-$715,451.79
3.32M
Mar 12
Form 4
∞
8.31K
—
—
8.31K
Nov 1
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Jul 12
Form 3
—
0
—
—
0
No matching records found

RESEARCH PHARMACEUTICAL SERVICES, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

COMFORCE CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Aug 13
No matching records found

NUCO2 INC /FL No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-11.00K
$30.00
-$330,000.00
0
May 28
Form 4
—
0
—
—
0
Feb 19
Form 4
+120.00%
6K
$12.50
$75,000.00
11K
Feb 8
Form 4
—
0
—
—
0
Feb 16
Form 4
-66.67%
-4.00K
$26.14
-$104,540.00
2K
Aug 24 - Aug 25
Form 4
-42.86%
-3.00K
$26.64
-$79,920.00
4K
Aug 21
Form 4
-23.08%
-6.00K
$26.54
-$159,000.00
20K
May 22 - May 23
Form 4
-16.67%
-2.00K
$28.61
-$57,220.00
10K
Feb 23
Form 4
—
0
—
—
0
Feb 16
Form 4
-31.82%
-5.60K
$29.43
-$164,961.88
12K
Feb 10
Form 4
—
0
—
—
0
Dec 7
Form 4
-89.87%
-70.89K
$25.74
-$1,835,935.59
7.99K
Jun 27 - Jun 28
Form 4
-51.41%
-75.00K
$22.84
-$1,713,000.00
70.89K
Mar 30
Form 4
-8.40%
-28.00K
$23.18
-$649,100.00
305.28K
Dec 6 - Dec 8
Form 4
-16.82%
-82.34K
$24.26
-$1,988,965.20
407.12K
Dec 1 - Dec 3
Form 4
∞
877
—
—
877
May 25
Form 4
—
0
—
—
0
Feb 16
Form 4
∞
14.64K
—
—
14.64K
Oct 16
Form 4
—
0
—
—
0
Sep 10
No matching records found